To address the question of whether IDO plays a negative regulatory role in an animal model of arthritis, we assessed IDO activity in the sera of mice at different stages of arthritis and the effect of 1-methyl-tryptophan (1-MT), a specific inhibitor of IDO, on arthritis development and antigen-specific immune responses in CIA. The gene discussed is IDO1; the disease is arthritic joint disease.